This is to inform you that the Board of Directors at ts meeting held on 4th April, 2025 has approved the alteration in the object clause of Memorandum of Association of the company. Also ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pentokey Organy India Ltd's Board of Directors, at a meeting held on April 4, 2025, approved changes to the Object Clause (Clause III(A)) of the company's Memorandum of Association. The amendment adds three new permitted business activities to the company's scope. The new objects cover manufacturing, trading, importing, exporting, and dealing in organic chemicals including pharmaceutical bulk drugs and formulations (both allopathic and ayurvedic). The second new object covers cosmetics, toilet goods, beauty aids, and orthopaedic/surgical appliances. The third broadens the scope to organic and inorganic chemicals, heavy chemicals, fertilizers, pesticides, petrochemicals, acids, and related products. The full disclosure was filed with BSE under SEBI LODR Regulation 30, with details provided in Annexure A.
This is a positive diversification signal, giving the company legal flexibility to enter pharmaceuticals, personal care, and broader chemical manufacturing. No immediate financial impact, but investors may view it as groundwork for future expansion into higher-growth sectors.